Skip to main content

Table 1 Demographic data for patients treated with pemetrexed plus platinum (n = 53).

From: Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients

Patient criteria

N (%)

Patient number

53

Median age (range)

52 (34--68)

Sex

 

   Male

39 (73.6)

   Female

14 (26.4)

Weight, kg: mean ± SD (range)

69 ± 10.1 (40--96)

Stage

 

   IIIB

15 (28.3)

   IV

38 (71.7)

ECOG Performance status

 

   0

4 (7.5)

   1

36 (67.9)

   2

13 (24.5)

Histology

 

   Adenocarcinoma

31 (58.5)

   Alveolar carcinoma

6 (11.3)

   Squamous carcinoma

14 (26.4)

   Large cell carcinoma

1(1.9)

   Mixed carcinoma

1(1.9)

No. chemotheraphy line

 

   Second line

34 (64.2)

   Third line

15 (28.3)

   Fourth lines

4 (7.5)